$461 Million is the total value of SPHERA FUNDS MANAGEMENT LTD.'s 91 reported holdings in Q1 2016. The portfolio turnover from Q4 2015 to Q1 2016 was 130.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | SELECT SECTOR SPDR TRput | $50,835,000 | – | 750,000 | +100.0% | 11.02% | – | |
| PFE | Buy | PFIZER INC | $42,285,000 | +11.3% | 1,426,612 | +21.2% | 9.16% | +64.8% |
| New | ISHARES TRput | $27,658,000 | – | 250,000 | +100.0% | 6.00% | – | |
| SHPG | Buy | SHIRE PLCsponsored adr | $16,479,000 | +101.0% | 188,676 | +371.7% | 3.57% | +197.4% |
| GILD | Buy | GILEAD SCIENCES INC | $15,864,000 | +9.9% | 172,700 | +21.0% | 3.44% | +62.7% |
| MYL | New | MYLAN N V | $13,326,000 | – | 287,827 | +100.0% | 2.89% | – |
| ORA | Buy | ORMAT TECHNOLOGIES INC | $13,267,000 | -65.8% | 322,193 | +18.3% | 2.88% | -49.3% |
| ITRN | New | ITURAN LOCATION AND CONTROL | $9,282,000 | – | 471,584 | +100.0% | 2.01% | – |
| V | Buy | VISA INC | $5,152,000 | +81.5% | 67,369 | +84.1% | 1.12% | +168.5% |
| New | SELECT SECTOR SPDR TRput | $4,500,000 | – | 200,000 | +100.0% | 0.98% | – | |
| ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $4,394,000 | +16.7% | 70,000 | +75.0% | 0.95% | +72.8% |
| GOOGL | New | ALPHABET INCcap stk cl a | $4,333,000 | – | 5,680 | +100.0% | 0.94% | – |
| VNDA | Buy | VANDA PHARMACEUTICALS INC | $4,281,000 | -0.5% | 512,051 | +10.8% | 0.93% | +47.3% |
| ACAD | Buy | ACADIA PHARMACEUTICALS INC | $4,194,000 | +17.6% | 150,000 | +50.0% | 0.91% | +74.1% |
| SAGE | Buy | SAGE THERAPEUTICS INC | $3,943,000 | -27.3% | 123,000 | +32.3% | 0.86% | +7.7% |
| ADMS | Buy | ADAMAS PHARMACEUTICALS INC | $3,904,000 | -8.1% | 270,000 | +80.0% | 0.85% | +36.0% |
| ESLT | New | ELBIT SYS LTDord | $3,242,000 | – | 34,456 | +100.0% | 0.70% | – |
| AAP | Buy | ADVANCE AUTO PARTS INC | $3,229,000 | +37.9% | 20,136 | +29.5% | 0.70% | +104.1% |
| CHTR | Buy | CHARTER COMMUNICATIONS INC Dcl a new | $3,225,000 | +337.6% | 15,930 | +295.7% | 0.70% | +547.2% |
| PTNR | Buy | PARTNER COMMUNICATIONS CO LTadr | $2,909,000 | +7.7% | 624,230 | +1.0% | 0.63% | +59.7% |
| RDUS | Buy | RADIUS HEALTH INC | $2,830,000 | -34.3% | 90,000 | +28.6% | 0.61% | -2.9% |
| PANW | New | PALO ALTO NETWORKS INC | $2,802,000 | – | 17,175 | +100.0% | 0.61% | – |
| NBIX | New | NEUROCRINE BIOSCIENCES INC | $2,769,000 | – | 70,000 | +100.0% | 0.60% | – |
| New | AMICUS THERAPEUTICS INCput | $2,535,000 | – | 300,000 | +100.0% | 0.55% | – | |
| FOLD | New | AMICUS THERAPEUTICS INC | $2,535,000 | – | 300,000 | +100.0% | 0.55% | – |
| DERM | New | DERMIRA INC | $2,482,000 | – | 120,000 | +100.0% | 0.54% | – |
| EIGR | New | EIGER BIOPHARMACEUTICALS INC | $2,474,000 | – | 147,514 | +100.0% | 0.54% | – |
| CYTK | New | CYTOKINETICS INC | $2,411,000 | – | 341,944 | +100.0% | 0.52% | – |
| New | NEURODERM LTD | $2,349,000 | – | 166,359 | +100.0% | 0.51% | – | |
| New | ACADIA PHARMACEUTICALS INCput | $2,237,000 | – | 80,000 | +100.0% | 0.48% | – | |
| ADRO | Buy | ADURO BIOTECH INC | $2,178,000 | -35.5% | 170,000 | +41.7% | 0.47% | -4.5% |
| APD | New | AIR PRODS & CHEMS INC | $2,114,000 | – | 14,672 | +100.0% | 0.46% | – |
| CHMA | New | CHIASMA INC | $2,113,000 | – | 230,649 | +100.0% | 0.46% | – |
| GLYC | New | GLYCOMIMETICS INC | $2,014,000 | – | 337,911 | +100.0% | 0.44% | – |
| MLNX | New | MELLANOX TECHNOLOGIES LTD | $1,997,000 | – | 36,760 | +100.0% | 0.43% | – |
| ICL | Buy | ISRAEL CHEMICALS LTD | $1,903,000 | +579.6% | 437,671 | +533.5% | 0.41% | +904.9% |
| VRX | Buy | VALEANT PHARMACEUTICALS INTL | $1,802,000 | -47.5% | 68,500 | +103.0% | 0.39% | -22.1% |
| NICE | New | NICE SYS LTDsponsored adr | $1,769,000 | – | 27,300 | +100.0% | 0.38% | – |
| WAB | Buy | WABTEC CORP | $1,721,000 | +89.5% | 21,704 | +70.1% | 0.37% | +180.5% |
| New | PORTOLA PHARMACEUTICALS INCcall | $1,634,000 | – | 80,100 | +100.0% | 0.35% | – | |
| PTCT | Buy | PTC THERAPEUTICS INC | $1,610,000 | -24.7% | 250,000 | +278.7% | 0.35% | +11.5% |
| CRVS | New | CORVUS PHARMACEUTICALS INC | $1,608,000 | – | 110,921 | +100.0% | 0.35% | – |
| BLUE | New | BLUEBIRD BIO INC | $1,275,000 | – | 30,000 | +100.0% | 0.28% | – |
| CATB | Buy | CATABASIS PHARMACEUTICALS IN | $1,159,000 | +81.1% | 230,041 | +184.9% | 0.25% | +167.0% |
| IGLD | New | INTERNET GOLD-GOLDEN LINES Lord | $678,000 | – | 50,250 | +100.0% | 0.15% | – |
| TSEM | New | TOWER SEMICONDUCTOR LTD | $0 | – | 0 | +100.0% | 0.00% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-05-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| TEVA PHARMACEUTICAL-SP ADR | 36 | Q3 2023 | 8.4% |
| MERCK & CO INC NEW | 35 | Q3 2023 | 8.4% |
| NICE Systems Ltd | 27 | Q3 2023 | 4.4% |
| BIOGEN INC | 26 | Q3 2023 | 6.7% |
| AMICUS THERAPEUTICS INC | 26 | Q2 2022 | 4.3% |
| PFIZER INC | 25 | Q3 2023 | 9.2% |
| SAREPTA THERAPEUTICS INC | 25 | Q3 2023 | 3.2% |
| JOHNSON & JOHNSON | 24 | Q3 2023 | 8.0% |
| UNIQURE NV | 23 | Q3 2023 | 1.2% |
| SYNDAX PHARMACEUTICALS INC | 22 | Q3 2023 | 3.9% |
View SPHERA FUNDS MANAGEMENT LTD.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cyclacel Pharmaceuticals, Inc. | February 06, 2023 | 250,000 | 2.0% |
| Altimmune, Inc. | February 14, 2022 | 1,244,241 | 3.1% |
| Allot Ltd. | February 16, 2021 | 1,129,054 | 3.2% |
| Larimar Therapeutics, Inc. | February 16, 2021 | ? | ? |
| Neos Therapeutics, Inc. | February 16, 2021 | ? | ? |
| Orgenesis Inc. | February 16, 2021 | 525,216 | 0.0% |
| Sio Gene Therapies Inc. | February 16, 2021 | ? | ? |
| X4 Pharmaceuticals, Inc | February 16, 2021 | 250,000 | 0.0% |
| Axovant Gene Therapies Ltd. | February 25, 2020 | 2,931,017 | 8.0% |
| Axovant Gene Therapies Ltd. | February 11, 2020 | 398,540 | 1.8% |
View SPHERA FUNDS MANAGEMENT LTD.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR/A | 2024-02-15 |
| 13F-HR | 2024-02-14 |
| SC 13G | 2024-02-08 |
| SC 13G/A | 2024-02-05 |
| SC 13G/A | 2024-02-05 |
| SC 13G/A | 2024-02-05 |
| SC 13G/A | 2024-02-05 |
| 13F-HR | 2023-11-14 |
| SC 13G | 2023-10-10 |
View SPHERA FUNDS MANAGEMENT LTD.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.